Cargando…
Overview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial Fluid
Every drug used to treat cancer (chemotherapeutics, immunological, monoclonal antibodies, nanoparticles, radionuclides) must reach the targeted cells through the tumor environment at adequate concentrations, in order to exert their cell-killing effects. For any of these agents to reach the goal cell...
Autores principales: | Baronzio, Gianfranco, Parmar, Gurdev, Baronzio, Miriam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512202/ https://www.ncbi.nlm.nih.gov/pubmed/26258072 http://dx.doi.org/10.3389/fonc.2015.00165 |
Ejemplares similares
-
Update on the challenges and recent advances in cancer immunotherapy
por: Baronzio, Gianfranco, et al.
Publicado: (2013) -
Mechanical Stress as the Common Denominator between Chronic Inflammation, Cancer, and Alzheimer’s Disease
por: Levy Nogueira, Marcel, et al.
Publicado: (2015) -
Radiation-induced changes in microcirculation and interstitial fluid pressure affecting the delivery of macromolecules and nanotherapeutics to tumors
por: Multhoff, Gabriele, et al.
Publicado: (2012) -
Tumor Interstitial Fluid Formation, Characterization, and Clinical Implications
por: Wagner, Marek, et al.
Publicado: (2015) -
Cytotoxic Activity of Peripheral Blood Mononuclear Leukocytes, Activated by Interleukin-2/β-Cyclodextrin Nanocomposition against Androgen Receptor-Negative Prostate Cancers
por: Anisimova, Natalia Yu., et al.
Publicado: (2011)